GPT Healthcare Limited
133.55
INR
-2.13
(-1.57%)
GPT Healthcare Limited
NSE:GPTHEALTH
(National Stock Exchange of India)
Recent
price
133.55
P/E
ratio
25.79
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- GPT Healthcare Limited, incorporated in 1989 and headquartered in Kolkata, West Bengal, India, operates as the healthcare arm of GPT Group and owns and manages a chain of multispecialty neighbourhood tertiary care hospitals under the ILS Hospitals brand across Eastern India; it provides integrated secondary and tertiary healthcare services including internal medicine and diabetology, nephrology with renal transplants, laparoscopic and general surgery, gynaecology and obstetrics, critical care and emergency services, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology and neurosurgery, paediatrics and neonatology, robotic-assisted procedures, bariatric and metabolic surgery, urology, ENT, dermatology, psychology, haematology, and minimally invasive gynaecological surgery; the company also operates clinics, pharmacies, diagnostic centres, and academic programs such as a GNM Nursing School and B.Sc. Nursing College at its Agartala facility, while offering pharmaceutical sales. The company serves densely populated underserved regions primarily in West Bengal, Tripura, and Chhattisgarh through five hospitals located in Salt Lake and Dum Dum (Kolkata), Howrah, Agartala, and Raipur, with a total capacity exceeding 700 beds supported by over 90 full-time consultants and 570 visiting consultants; it targets local communities with affordable, high-quality care and has treated over 600,000 patients since inception. Recent developments include the commercialization of its Raipur hospital in fiscal 2025, the signing of a memorandum of understanding for a new 150-bed facility in Jamshedpur with an estimated investment of INR 65-70 crore expected by end-Q3 fiscal 2027, the introduction of robotic knee surgeries and comprehensive oncology services at select hospitals, expansion of cardiothoracic offerings, and maintenance of a near debt-free balance sheet amid revenue growth to INR 430 crore in the latest fiscal year.